Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Net Current Assets

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Current Assets (Including Current Investments) ₹-13 Cr₹99 Cr₹66 Cr₹154 Cr

What is the latest Net Current Assets ratio of CORONA REMEDIES ?

The latest Net Current Assets ratio of CORONA REMEDIES is ₹-13 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹-13 Cr
Mar2025₹99 Cr
Mar2024₹66 Cr
Mar2023₹154 Cr

How is Net Current Assets of CORONA REMEDIES Trending?

Years Net Current Assets % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹99 Cr
51.06
Mar2024 ₹66 Cr
-57.35
Mar2023 ₹154 Cr -

Compare Net Current Assets of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,163.2 Cr 6.6% 1.9% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

6.6%

1.9%

NA
SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses